
About Discovery Life Sciences
Discovery Life Sciences is a company based in Huntsville (United States) founded in 2006. Discovery Life Sciences has completed 7 acquisitions, including AllCells, East West Biopharma and In vitro ADMET. Discovery Life Sciences offers products and services including Biospecimens, Tumoroids, Genomics Services, and PBMCs. Discovery Life Sciences operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
Products & Services of Discovery Life Sciences
Discovery Life Sciences offers a comprehensive portfolio of products and services, including Biospecimens, Tumoroids, Genomics Services, and PBMCs.
High-quality human biospecimens for research studies
Cultured tumor models for oncology research applications
RNA and DNA sequencing for translational studies
Peripheral blood mononuclear cells for immune research
Apps and channels of Discovery Life Sciences
its YouTube channel Discovery Life Sciences has 23 subscribers.
Funding Insights of Discovery Life Sciences
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Discovery Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | – | Seed | β | PacBio | β |
1 investors in total: 1 institutional.
Investors in Discovery Life Sciences
Discovery Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PacBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | pacb.com | Menlo Park, United States |
Investor details for Discovery Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Discovery Life Sciences
9 people are tracked at Discovery Life Sciences (6 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Heather Allison | Director Of Human Resources | Leadership |
Erin Kirkland | Senior Human Resources Business Partner | Leadership |
J'Darrian Russell | Director, Global Talent Acquisition | Leadership |
Tamara Bowles | Chief Human Resources Officer | Leadership |
Tiffany Burwell | HR Project Management Director | Leadership |
Irjad Ajvazi | Human Resources Director | Leadership |
Brittany Banks Mhrm | Human Resources Coordinator | Team |
Giselle Areli Chombo Sanchez | Hr-office Coordinator | Team |
Lisa Goodman | Human Resources Generalist | Team |
Complete people profiles for Discovery Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Discovery Life Sciences
Discovery Life Sciences has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include AllCells, East West Biopharma and In vitro ADMET.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CRO focused on hematotoxicity assays and primary cells | reachbio.com | Seattle, United States | 2007 | Apr 2023 | β’β’β’β’ | |
Human and animal primary cells with associated media are provided. | allcells.com | Alameda, United States | 1998 | Jul 2022 | β’β’β’β’ | |
In vitro ADMET services are provided via proprietary IdMOC assays. | invitroadmet.com | Columbia, United States | 2004 | Dec 2021 | β’β’β’β’ | |
Biomarkers are developed and analyzed for clinical trials by Targos. | targos-gmbh.de | Kassel, Germany | 2005 | May 2021 | β’β’β’β’ | |
Clinical research services are provided across multiple therapeutic areas. | ewbiopharma.com | Kyiv, Ukraine | 2003 | Nov 2020 | β’β’β’β’ | |
Immunohistochemistry services are offered for biomarker discovery and diagnostic assays. | qmlabs.com | Santa Barbara, United States | 1997 | Nov 2019 | β’β’β’β’ | |
Provider of customized tissue procurement services for biopharmaceutical firms | sofiabio.com | Sofia, Bulgaria | 2005 | Feb 2019 | β’β’β’β’ |
Complete acquisition details for Discovery Life Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Discovery Life Sciences
9 dated milestones of Discovery Life Sciences across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Discovery Life Sciences is founded.
- Acquisition Acquires Sofia Bio.
- Funding First funding round.
- Acquisition Acquires QM Labs.
- Acquisition Acquires East West Biopharma.
- Acquisition Acquires Targos.
- Acquisition Acquires In vitro ADMET.
- Acquisition Acquires AllCells.
- Acquisition Acquires ReachBio Research Labs.
Competitors of Discovery Life Sciences
Discovery Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of Discovery Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Discovery Life Sciences
The website of Discovery Life Sciences (dls.com) receives about 24.6K visits a month.
- Monthly visits24.6K
▲ 25.3% vs previous month
Websites whose visitors overlap most with Discovery Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aacr.org | 100% | 321.9K | #142,787 | View details | |
| carislifesciences.com | 63% | 38.2K | #745,593 | View details | |
| directlabs.com | 61% | – | #751,525 | View details | |
| qbdgroup.com | 60% | – | #976,787 | View details | |
| precisionformedicine.com | 60% | 36.8K | #1,000,701 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 6 similar websites and full traffic analytics for Discovery Life Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Discovery Life Sciences
Complete news archive for Discovery Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Discovery Life Sciences
10 companies that operate in the same segment as Discovery Life Sciences (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Discovery Life Sciences
Discovery Life Sciences was founded in 2006 and raised its 1st funding round 13 years after it was founded.
Discovery Life Sciences is headquartered in Huntsville, United States. It is registered at Huntsville, Alabama, United States.
Discovery Life Sciences provides diversified services with integrated technology platforms for drug discovery. The company offers services in biopharma, diagnostic, scientific consulting, and laboratory research solution. Biopharma services include histopathophysiology, characterization of biospecimens, and cell isolation services. It also offers biobank services which enable access to research samples, diagnostic specimens, and human biofluids. The consulting services include flow cytometry analysis and panel design, tissue dissociations, cell isolations, cell culturing, analyte determination and quantification, compound validation, and others.
Discovery Life Sciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Discovery Life Sciences offers Biospecimens, Tumoroids, Genomics Services, and PBMCs.
Discovery Life Sciences has made 7 acquisitions, including AllCells, East West Biopharma, and In vitro ADMET.
Discovery Life Sciences has 1 investor. Key investors include PacBio.
Discovery Life Sciences operates through Discovery Life Sciences, Inc..
